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Perturbation of the plasma membrane of  the macrophage by certain pharmacologic, 
immunologic, or particulate stimuli provokes a  burst of extramitochondrial respira- 
tion, leading to the secretion of partially reduced forms of molecular oxygen, such as 
superoxide anion (1) and hydrogen peroxide (2). These reactive oxygen intermediates 
can lyse tumor cells within a few hours after stimulation of the activated macrophage 
respiratory burst (3-6). 
With  more prolonged incubation,  activated  macrophages  sometimes  lyse tumor 
cells spontaneously, that is, in the absence of agents known to trigger the respiratory 
burst  (7).  Several oxygen-independent mechanisms of spontaneous macrophage-me- 
diated  cytotoxicity have  been  described  (8-11).  It  is  less  clear  whether  oxygen- 
dependent mechanisms can also play a  role (12-16).  In fact, there is little evidence 
that macrophages secrete consequential amounts of reactive oxygen intermediates in 
the absence of exogenous triggering agents (1, 2). 
To investigate this issue, we made use of the unique peroxidase (EPO) 1 contained 
in the granules of eosinophils (17). This enzyme, which is distinct from myeloperoxi- 
dase,  enhances  the  destruction of fungi  (18),  bacteria  (19-21),  schistosomula  (22), 
toxoplasma (23), trypanosoma,  2 mast cells (24), and tumor cells (25)  in the presence 
of  exogenous H~O2 and halide. EPO is highly cationic (21) and can adsorb to microbes 
such as Staphylococcus aureus (26), Toxoplasma gondii (23), and T~ypanosoma cruzi, 2 markedly 
potentiating their killing during phagocytosis by mononuclear phagocytes. We asked 
whether EPO adsorbed  to tumor cells would  enhance spontaneous cytotoxicity by 
activated macrophages. 
Materials and Methods 
Purification of EPO.  EPO was purified from horse eosinophils as previously described  (21). 
Briefly, eosinophils were isolated in 98-100% purity from 10-40 liters of horse blood, the EPO 
* Supported by U. S. Public Health Service grants CA-22090, AI-07763, and HD-02266, and by a grant 
from the Rockefeller Foundation. 
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extracted with 0.05 M  sodium acetate buffer, pH 4.7, containing 0.18 M  sodium chloride, and 
the enzyme purified by chromatography on Sephadex G-200 and carboxymethylcellulose. The 
final product, which was present in 0.05 M  sodium acetate buffer, pH 4.7, with  1.0 M  sodium 
chloride, had a  415/280  nm optical density ratio of >0.9.  Peroxidase activity was determined 
by guaiacol oxidation (27).  1 U  of enzyme is the amount that oxidizes 1/~mol of guaiacol/min 
at 25°C, using a molar absorbancy for the product, tetraguaiacol, of 2.66 ×  104 cm  -1 at 470 nm 
(28).  The activity of freshly prepared  stock solutions ranged from  112  to 340 U/ml. Aliquots 
(10-50/H) of the EPO preparation were frozen in microhematocrit tubes and thawed just before 
use~ 
Treatment  of Tumor  Cells  with  EPO.  Tumors  were  carried  as  ascites  in  the  mouse  strains 
indicated:  LSTRA lymphoma  (BALB/c), TLX9 and  NK lymphomas  (C57BL/6),  and  P815 
mastocytoma [(BALB/c ×  DBA/2)FI (CD2F,)].  TLX9 and P815 were also maintained for up 
to 3 wk in stationary suspension culture in Eagle's minimum essential medium (alpha variant) 
with  100/~g/ml streptomycin and  100  U/ml penicillin, containing  10% horse serum heated at 
56°C  for  30  rain  (MEM-10%  HS).  Tumor  cells were  labeled  with  Na251CrO4  as  previously 
described  (ref.  29 for LSTRA; ref. 30  for TLX9,  NK, and  P815).  For coating of tumor cells 
with EPO,  15 ×  106 LSTRA cells in 0.5 ml of Hanks' balanced salt solution containing 0.001% 
gelatin and  10 mM glucose, or  1 ×  106-3  ×  106 TLX9, NK, or P815 cells in 0.5 ml of Krebs- 
Ringer buffer containing 6  mM phosphate  and  5.5  mM glucose, were incubated  with  10-20 
/H of the EPO preparation  for 10-15 rain at  37°C. The dilution of the stock EPO preparation 
was >25 times, so that the final acetate buffer and sodium chloride concentrations contributed 
by the enzyme preparations  were <0.002  M  and 0.04  M, respectively. The cells were washed 
twice and suspended in 0.1  M  phosphate buffer pH 7.0 (for LSTRA), MEM-5% HS (for TLX9 
and  P815),  or  MEM-0.25%  HS  (for  NK  lymphoma).  Control  (uncoated)  tumor  cells  were 
treated  identically,  except  that  EPO  was  not  added.  The  cells were  counted  and  viability 
assessed with 0.2% trypan blue in a  hemocytometer. 
Effector  Cells. Peritoneal  cells were  collected  from  untreated  or  variously  injected  CD2FI 
female mice, washed, enumerated,  and counted differentially as described in detail elsewhere 
(2,  3,  5).  The cells were suspended  at 3  ×  105/0.1  ml of MEM-5% HS (for use with TLX9 or 
P815 cells) or MEM-0.25% HS (for use with NK lymphoma cells), except where noted otherwise. 
Where indicated,  7 ×  106 peritoneal cells in 2 ml Krebs-Ringer buffer were layered on top of 
3 ml of Ficoll-Paque (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway,  N J) in 
a  15-ml tube, and centrifuged at 300 g for  10 min at 4°C. The upper, mononuclear cell layer 
was washed three times in the medium used for the assay. 
Cytolysis Assay.  For studies  performed  in  the absence  of effector cells, uncoated  and  EPO- 
zoated target cells were incubated with the components of the reaction mixture as described in 
the legends to Tables and  Figures. With LSTRA, the reaction was conducted in  10 ×  75-mm 
polystyrene  test  tubes  (2054;  Falcon  Labware,  Oxnard,  CA)  and  ~Cr release determined  as 
previously described  (29).  With the other tumor cells, microtest plates were used as described 
below. 
For studies  using  effector cells and  target  cells, 0.1  ml  of each  were  dispensed  to  round- 
bottomed microtest plates  (Flow Laboratories,  Rockville, MD) containing 0.02  ml of phorbol 
myristate acetate (PMA) diluted in dimethylsulfoxide (DMSO) or DMSO alone (final concen- 
tration,  0.033%  DMSO  with or without  100  ng/ml  PMA).  Where  indicated,  catalase  (from 
beef liver, type C100, Sigma Chemical Co., St. Louis, MO) or sodium azide (Fisher Scientific 
Co., Pittsburgh,  PA) were diluted  in normal saline and  added  in a  volume of 0.02  ml to the 
assay  wells.  Catalase  was  inactivated  by  boiling  for  20  min,  reconstituting  to  the  original 
volume with distilled water, and sonicating 15-30 s (power output  I, Heat Systems-Ultrasonics 
Inc., Plainview, NY) to disperse the precipitate. The plates were incubated at 37°C in 5% COz/ 
95% air for 4.5 h and centrifuged. Gamma emissions were counted in 0.1 ml of each supernatant. 
Percent specific lysis for triplicate cultures was calculated as (A -  B)/(C -  B), where A equals 
percent release of ~lCr in the presence of effector cells, B equals percent release in the absence 
of effectors, and C  equals percent of the total label that was releasable in the presence of 0.2% 
Triton X-100  (Sigma Chemical Co.). The simple proportional  SEM for triplicates was calcu- 
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whereas "spontaneous lysis"  refers  to specific  lysis in the presence of effector cells but in the 
absence of PMA. 
Percent Inhibition. Inhibition of EPO-dependent cytolysis by catalase or azide was expressed as 
100 (D -  E +  F)/D, where D equals specific lysis of EPO-coated tumor cells in the absence of 
catalase or azide, E equals specific lysis of EPO-coated targets in the presence of either agent, 
and F equals specific  lysis of targets not coated with EPO. The value of F averaged 8.2% and 
was the same whether or not  catalase  or azide was present.  In computing E,  the  term  for 
spontaneous release  pertained to tumor cells incubated with the same concentration of catalase 
or azide but without effector cells. No concentration of either agent as used here significantly 
affected the spontaneous release  of 51Cr. 
Other Reagents and Procedures. 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) was from Bristol 
Laboratories, Syracuse, NY. Where indicated,  protamine sulfate  (preservative  free;  Eli  Lilly 
and Co., Indianapolis, IN) was used in place of EPO at a concentration of 0.06 mg/ml. Glucose 
oxidase  (GO)  from Aspergillus niger (Type  V)  was  from  Sigma  Chemical  Co.  The  rate  of 
production of H202 was assayed by the scopoletin method (2). All other details of procedure, 
and the sources of mice and materials, were as previously reported (3, 5, 30). 
Results 
Increased Sensitivity  of EPO-coated  Tumor  Cells  to Lysis by H202.  In an earlier  study 
(25), EPO from guinea pig peritoneal cells sensitized LSTRA lymphoma cells to lysis 
by  10  .4  M  preformed  H202  in the  presence of a  halide.  We confirmed this  finding 
with  a  highly  purified  preparation  of horse  EPO,  and  in  addition  determined  the 
effect of allowing the EPO to bind to the surface of the tumor cells by preincubation. 
Table  I  demonstrates  the  toxic effect of H202  and  a  halide  on  LSTRA lymphoma 
cells with surface-bound EPO. Each component of the toxic system (EPO, H202, and 
halide)  was required.  The hemeprotein  inhibitors  azide, cyanide, and aminotriazole 
decreased  the toxicity. Under the conditions used, iodide was effective at concentra- 
tions  down  to  10  .5  M  and  bromide  to  10  .4  M.  Chloride  was  ineffective at  0.1  M. 
Damage  to  EPO-coated  tumor  cells  was  evident  within  5  min  of incubation  with 
H202 and  iodide, and reached a  maximum at  30 min, under the conditions used in 
Table II. 
Protein  inhibits  the toxicity of the  free peroxidase-H202-halide  system.  However, 
cytotoxicity mediated by cell-bound EPO was markedly less sensitive to inhibition by 
protein. This is shown in Table III. When free EPO was used, human serum albumin 
inhibited  toxicity partially at a  concentration of 4  mg/100 ml and completely at 40 
mg/100  ml.  In contrast,  an  albumin  concentration  of 8  g/100 ml was required  for 
inhibition  when  EPO  was bound  to the  target  cell  surface.  Similarly,  0.05%  serum 
partially and 0.2% serum completely inhibited  toxicity with free EPO, whereas with 
cell-bound  EPO,  30%  serum  caused  only  partial  inhibition,  and  inhibition  was 
incomplete at the highest serum concentration employed (40%). 
We next undertook studies with three additional tumor cell lines (TLX9 lymphoma, 
P815 mastocytoma, and NK lymphoma), which vary widely in their susceptibility to 
lysis by H202 (TLX9 >  P815 >  NK)  (30), and have been used in earlier studies of the 
role of H2Oz in macrophage-mediated  cytotoxicity (3, 5, 30). To mimic the manner 
in  which  HzO2  is  delivered  by macrophages,  we added  glucose  oxidase  (GO)  plus 
glucose,  thereby  generating  a  flux  of H202.  We  suspended  the  tumor  cells  in  a 
complex, serum-containing medium at pH 7.4, without additional iodide or bromide. 
The  tumor  cells  were  exposed  to  EPO  and  then  washed  to  remove  unbound 
enzyme. Such cells showed no signs of toxicity, compared with cells without surface- 
bound  EPO, as judged by exclusion of trypan  blue or retention  of SlCr  (Table  IV). 1294  EOSINOPHIL  PEROXIDASE  AND  MACROPHAGE-MEDIATED  CYTOLYSIS 
TABLE  I 
Toxicity of Tumor Cell-bound EPO* 
Tumor cell cytotoxicity  p~  p§ 
Supplements  (percent 51Cr release) 
None 
LSTRA-EPO +  H202 +  iodide (10 -4 M) 
LSTRA-EPO +  H202 +  iodide (10 -5 M) 
Iodide omitted 
H202 omitted 
EPO omitted 
Azide  (10  -3 M) added 
Azide (10 -4 M) added 
Azide (10 -5 M) added 
Azide (10 -s M) added 
Cyanide (10 -a M) added 
Cyanide (10 -4 M) added 
Cyanide (10 -5 M) added 
Cyanide (10  s M) added 
Aminotriazole (10 -3 M) added 
Aminotriazole (10 -4 M) added 
Aminotriazole (10 -5 M) added 
Aminotriazole (10 -6 M) added 
LSTRA-EPO +  H202 +  iodide (10 -~ M) 
LSTRA-EPO +  H202 +  iodide (10  -7 M) 
LSTRA-EPO +  H202 +  bromide (10  -3 M) 
LSTRA-EPO +  H202 +  bromide (10-4 M) 
LSTRA-EPO +  H202 +  bromide (10  -s M) 
LSTRA-EPO +  H202 +  bromide (10 -6 M) 
LSTRA-EPO +  H202 +  chloride (0.1 M) 
10.9 +  1.4 (3)11 
66.2 ::!: 1.6 (3) 
60.5 +  0.9  (6) 
12.0 +  1.8  (3)  <0.001 
11.9 _  1,6 (3)  <0.001 
6.9 +  0.6  (3)  <0,001 
10.8 ±  0,5  (3)  <0,001 
10.4 +  0.7  (3)  <0.001 
11.7 ±  0.4  (3)  <0.001 
54.7 ±  1.9 (3)  <0.02 
11.8 ±  1.t  (3)  <0,00l 
14.3 ±  2.2 (3)  <0,001 
37.6 ±  6.3  (3)  <0.002 
59.9 ±  2.9 (3)  NS¶ 
12.9 ±  1.6 (3)  <0.001 
17.0 ±  4.2  (3)  <0.001 
54.1 ±  1.4 (3)  <0.01 
61.1 ±  0.8  (3)  NS 
18.3 ±  4.7  (3) 
14.9 +  4.2  (3) 
65.0 +  9.6  (3) 
55.4 ±  12.0 (3) 
33.2 ±  13.4 (3) 
17.3 ±  5.3  (3) 
13.9 ±  3,1  (3) 
<0.001 
<0.001 
NS 
NS 
<0.01 
<0.05 
NS 
NS 
NS 
* The reaction mixture contained 3 X  10  -2 M sodium phosphate buffer pH 7.0, 1.5 ×  10 -a M  MgSO4, 1.5 
X  10  -a  M  KH2PO4, 6.7  X  10  -2  M  Na2SO4,  0.005%  gelatin,  and  the supplements where indicated  as 
follows:  l0  s  SlCr  LSTRA  tumor cells  with  bound  EPO  (LSTRA-EPO);  10 -5  M  H202,  and  iodide, 
bromide, chloride,  azide,  cyanide,  or aminotriazole  (sodium salts)  at  the concentrations indicated.  In 
tubes with "EPO omitted", LSTRA cells were used without preincubation with EPO, and when 0.1  M 
NaCI was used, the 6.7  X  10  -2 M  Na2SO4 was deleted.  Incubation 30 min. 
P value for the difference from the complete system (LSTRA-EPO +  H202 +  10 -5 M  iodide). 
§ P value for the difference from the standard salt solution alone (None). 
H  Mean +  SE of (n) experiments. 
¶ Not significant. 
TABLE II 
Kinetics of Tumor Cell Cytotoxicity 
Time 
Tumor cell cytotoxicity (percent 51Cr release) 
Control  LSTRA-EPO +  H202 +  I- 
?flirt 
5  10.9  42.5 
15  12.8  62.1 
30  16.1  70.2 
60  16.0  70.8 
The reaction  mixture was as described  in Table I  with either LSTRA-EPO 
alone  (control) or LSTRA-EPO +  H202  +  I-  (10  -~ M).  Incubation was for 
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TABLE  III 
Effect of Albumin or Serum on the Cytotoxic Activity  of the Free or Tumor Cell-bound EPO System * 
Tumor cell cytotoxicity  (percent SaCr Release) 
Albumin or 
serum 
EPO  LSTRA-EPO 
Control  Complete  p:~  p§  Control  Complete system  P:~  P§ 
system 
None 
Albumin 
Serum (%) 
mg/I00 ml 
2 
4 
10 
20 
40 
200 
2,000 
4,000 
8,000 
10.7 ±  Lt (6) I[ 
10.5 ±  0.6 (3) 
7.5 ±  0.9 (3) 
8.2 ±  1.1  (3) 
7.6 ±  0.6 (4) 
8.0 ±  0.3 (3) 
7.9 ±  0.9 (3) 
0.02  109 ±  0.5 (3) 
0.05  I 1  2  ±  0.4 (3) 
0.1  9.3±2.3(3) 
0.2  8.9 ±  0.8 (3) 
1  7.7  ±  1.2  (3) 
10  I1.1 ±  2,0 (2) 
2O 
3O 
4O 
62.2 ± 2.4 (6)  <0.0£11 
54.7 ±  5.7 (3)  <0.002  NS¶ 
47.4 ±  6.3 (3)  <0.01  <0.05 
35.9 ±  7.4 (3)  <0.05  <0.01 
16.2 ±  2.9 (4)  <0.05  <0.001 
8.9 ±  0.6 (3)  NS  <0,001 
6.6 ±  0,7 (3)  NS  <0.001 
55.2 ±  1.2 (3)  <0.001  NS 
43.0 ±  1.6 (3)  <0.001  <0.002 
29.4 ±  6.7 (3)  <0.05  <0.001 
11.9 ±  3.2 (3)  NS  <0,001 
9.3 :t: 1,0 (3)  NS  <0.001 
8.5 ±  1.6 (3)  NS  <0.001 
17.6±3.1(4)  65.0±32(4)  <0.001 
11.4 ±  2.2 (4)  65.6 +  3.2 (4)  <0.001  NS 
10.4 ±  1.5 (4)  51.3 ±  7.5 (4)  <0.002  NS 
9.4 +  1.4 (4)  41.5 ±  9.3 (4)  <0.02  NS 
10.4 ±  2.4 (3)  24.9 ±  11,2 (3)  NS  <0.02 
11,4 +  1.6 (4)  65.7 ±  2.4 (4)  <0.001  NS 
11.6 +  1.3 (4)  59.1 ±  4.2 (4)  <0.001  NS 
11.6 ±  1.4 (4)  49.9 +  3.2 (4)  <0.001  <0.02 
10.9 ±  2.4 (3)  40.4 ±  0.9 (3)  <0.001  <0.002 
* The reaction  mixture was as described in Table I with either LSTRA cells and free EPO ("EPO') or LSTRA with surface-bound  EPO (~q,STRA- 
EPO"). Control tubes did not contain any other components of the peroxidase system whereas the complete EPO system contained 224 mU EPO, 10  5 
M  H20,e, and  10 4 M  iodide. Human serum albumin or pooled human serum was added at the concentrations indicated. 
* P value for the difference between the control and complete system 
§ P value for the difference between the complete system with albumin or serum and the complete system without albumin or serum. 
II Mean ±  SE of (n) experiments. 
¶ Not significant. 
TABLE IV 
Lack of Toxicity of EPO Alone * 
Tumor  Experi- 
ments 
Percent  cells excluding  trypan  blue 
Percent  spontaneous 
release  of 51Cr 
EPO-  EPO+  EPO-  EPO+ 
TLX9  14  97.7  +  0.4:t:  94.6  ±  1.0  7.6 +  0.4  10.9 ±  1.0 
NK  7  93.6  ±  2.0  93.8  +  3.7  12.0 ±  0.7  12.4 ±  0.8 
P815  3  98.9  ±  0.6  96.8  ::1:0.9  8.6  ±  2.5  8.6  ±  2.3 
*  51Cr-labeled  control  and  EPO-coated  tumor  cells  were  assessed  for  viability  by  trypan  blue  exclusion 
immediately  after  cell preparation  and  by  51Cr-release  4.5 h  later. 
Means  ±  SEM  for  the  number  of experiments  shown. 
Moreover, mice injected with  106 EPO-coated P388 cells died at  10.7 +  0.4 d, which 
was no later than mice injected with control P388 cells (11.4 +  0.7 d, seven mice per 
group).  However, when exposed  to GO plus glucose, EPO-coated TLX9  lymphoma 
cells were 15 times more sensitive and NK lymphoma cells 76 times more sensitive to 
lysis by H202 than were control, uncoated tumor cells, as judged by the flux of H202 
required for 50% specific lysis (Fig.  1). 
EPO alone did not affect the amount of GO necessary to attain 50%  lysis of P815 
mastocytoma cells  (Table V).  However, BCNU  inactivates  glutathione reductase in 1296  EOSINOPHIL  PEROXIDASE  AND  MACROPHAGE-MEDIATED  CYTOLYSIS 
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FIG.  1.  Sensitivity of lymphoma cells to lysis by enzymatically generated H202 with or without 
•  4  Sl,  ed  T  r  NK  prior exposure to EPO. The reaction mixture contained 4 X  10  Cr-label  LX9 (0, O) o 
(&, A) |ymphoma cells with (0, &) or without (O, A) bound EPO in 0.2 ml of MEM-5% HS with 
5.5 mM glucose (TLX9) or MEM-0.25% HS with 40 mM glucose  (NK). A range of concentrations 
of GO in 0.02 ml of normal saline was added to individual wells, and 51Cr release determined after 
4.5 h of incubation. Glucose was at a higher molarity with NK cells so that higher concentrations 
of GO could be tested without depleting the medium of glucose.  The rate of HzOz generation by 
GO was measured in Krebs-Ringer phosphate buffer with 5.5 mM or 40 mM glucose,  using the 
scopoletin method, and is indicated on a logarithmic scale on the abscissa.  Data points are means 
of triplicates, for which SEM averaged 2.6 :k 0.5%. Spontaneous release of 51Cr in the absence of 
GO was:  7.5% (TLXg, EPO-);  7.0% (TLX9, EPO+);  13.0% (NK, EPO-);  10.8% (NK,  EPO+). 
NK lymphoma cells were more sensitive to GO than in a previous study (30) presumably because 
the serum concentration was lower. 
TABLE  V 
Synergy Between EPO and BCNU in Augmenting Peroxide-Mediated Lysis of 
P815 Cells* 
LDso for un-  Ratio of LDs0 of untreated/treated cells 
Experiment  treated cells 
EPO  BCNU  EPO +  BCNU 
1  0.50  0.93  4,66  13.59 
2  0.96  1.10  4.29  11.06 
* The reaction mixture was as described in Fig.  1 except that 2 ×  104 P815 
cells in 0.2 ml of MEM-5% HS containing 5.5 mM glucose  were used.  The 
cells were either untreated, coated with EPO, incubated with 100/~g/ml of 
BCNU for 10 min, or both coated with EPO and treated with BCNU. The 
nmol of H202/min generated by the amount of glucose  oxidase needed to 
produce 50% specific ~ICr release in 4.5 h (LD~0) was determined. 
P815  cells and  sensitizes them  to peroxide-mediated  lysis  (30).  As shown  in Table  V, 
the sensitivity of P815 cells to H202 was increased four- to fivefold by prior exposure 
to BCNU.  The  sensitivity of BCNU-treated  P815  cells to H202 was  further increased 
2.8-fold by surface-bound  EPO. 
Augmentation of PMA-triggered,  Macrophage-mediated Cytolysis  by EPO.  We  next tested 
the effect of EPO  on cytolysis caused  by H202  secreted  by macrophages  in response 
to PMA  (4). EPO-coated  tumor  cells were much  more readily lysed by PMA-triggered, 
bacillus  Calmette-Gu~rin  (BCG)-elicited  macrophages  than  were  native  tumor  cells 
(Table  VI).  With  the  relatively  peroxide-resistant  NK  lymphoma  (30),  no  macro- 
phage-mediated  lysis of tumor  cells was  observed  without  EPO,  whereas  100%  lysis 
was  attained  when  PMA-triggered,  BCG-elicited  macrophages  were  incubated  with 
EPO-coated  NK  lymphoma  cells at effector/target  (E/T)  ratios of 5:1  to 45:1  (Table CARL  F.  NATHAN  AND  SEYMOUR  J.  KLEBANOFF  1297 
VI, Fig.  2).  Similarly, in one experiment,  EPO  on the surface of NK  lymphoma  ceils 
greatly  increased  their sensitivity to  lysis by  PMA-triggered,  casein-induced  macro- 
phages.  Resident  macrophages,  however,  did  not  lyse  control  or  EPO-coated  NK 
targets under  our experimental  conditions  (Table VI). 
With  TLX9  lymphoma  cells, the partial  lysis observed when  uncoated  tumor  cells 
were  exposed  to  PMA-triggered,  BCG-elicited  peritoneal  cells  was  considerably  in- 
creased when  the target  cells were coated with  EPO  (Table VI,  Fig.  3).  Comparison 
of E/T  ratios at 50% lysis (0.3 for coated and  9.6 for uncoated  TLX9)  suggested  that 
PMA-stimulated,  BCG-elicited peritoneal cells were ~32 times more efficient at lysing 
EPO-coated  TLX9  than  native  TLX9  (Fig.  3).  Even  peritoneal  cells  elicited  with 
thioglycollate  medium  lysed  EPO-coated  targets  in  the  presence  of PMA.  Resident 
peritoneal cells did so in one of four experiments  (Fig.  3). 
Spontaneous  Macrophage-mediated  Cytolysis  of EPO-coated  Tumor  Cells.  In  contrast  to 
uncoated  target  cells,  EPO-coated  NK  and  TLX9  lymphoma  cells  were  lysed  to  a 
substantial  extent by BCG-elicited peritoneal cells in the absence of PMA  (Table VI 
and  Figs.  2  and  4). Caseinate-elicited cells were also effective in one experiment  with 
NK  lymphoma  cells  (Table VI). 
TABLE  VI 
Augmentation of PMA-induced and Spontaneous Cytolysis by EPO 
PMA-induced lysis§ 
Target  Effector  Number  Number 
cells*  cells~:  of exper-  EPO-  EPO+  of exper- 
iments  iments 
Spontaneous lysis[[ 
EPO-  EPO+ 
NK 
TLX9 
BCG¶  3  10.6 ±  4.4**  [02.3 ±  5.3  4  3.1 ±  0.9  61.4 ±  5.7 
BCG-FH:~*  l  4.7  96.7  3  7.5± 2.8  31.5 ±  6.5 
Casein§§  1  0.3  80.5  1  -  1.1  29.9 
Res[[[[  2  -1.3±0.1  -0.5±  1.2  2  -0.9±0.1  0.8±0.6 
PMN¶¶  3  61.1 ±  7.7  87.2±  10.5  3  -2.0--0.6  13.8± 7.1 
BCG  8  33.3±9.2  84.9_-.7.6  9  9.1±  1.6  48.4±8.3 
Casein  1  -0.3  50.0  1  -0.1  16.8 
Thio¶***  2  7.4± 5.6  71.3 ±  8.6  2  0.3 ±  0.3  5.3 ±  2.9 
Res  4  0.7± 0.4  13.5 ±  9.2  5  0.2 ±  0.4  0.1 _+ 0.4 
PMN  4  40.6± 20.5  77.9± 4.5  8  1.1 ±0.4  13.3± 4.9 
*2X  104. 
:~ 3 ×  l0  s, except two experiments with Res cells at 8 ×  105. 
§ Specific  release of nlCr after 4.5  h with effector cells  in the presence of 100 ng/ml PMA in 0.033% 
DMSO. 
[[ Specific  release of 51Cr after 4.5 h with effector cells in the presence of 0.033% DMSO. 
¶ Peritoneal cells  from mice injected intraperitoneally 10 d  to 6 wk earlier with 7 ×  106 viable BCG, 
averaging 45.5 +  2.2% macrophages and 11.5 +  1.4% granulocytes. 
** Mean ±  SEM for the number of experiments indicated. 
~: BCG peritoneal cells depleted of granulocytes on Ficoll-Hypaque, averaging 59.6 +  5.8% macrophages 
and 1.7 ±  0.2% granulocytes. 
§§ Peritoneal ceils  from mice injected intraperitoneally with  1 ml of 6% sodium caseinate 5 d  earlier, 
averaging 62.1 ±  1.6% macrophages and 8.6 ±  1.8% granulocytes. 
[[[[ Peritoneal cells from untreated mice, averaging 52.3 ± 6.4% macrophages and 2.0 ± 0.8% granulocytes. 
¶¶ Peritoneal cells from mice injected intraperitoneally 16-20 h earlier with 1 ml 6% sodium caseinate (six 
experiments),  1 ml of 10% thioglycollate medium (one experiment), or  1 ml of 3% proteose peptone 
(two experiments), averaging 38.0 ±  2.7% macrophages and 55.8 ±  3.5% granulocytes. 
*** Peritoneal cells  from  mice  injected intraperitoneally with  1 ml  of  10% thioglycollate medium  5  d 
earlier, containing 69.2 ±  12.4% maerophages and 24.9 ±  10.8% granulocytes. 1298  EOSINOPHIL PEROXIDASE  AND MACROPHAGE-MEDIATED CYTOLYSIS 
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FI~.  2.  Effect of E/T cell ratio. O, O show spontaneous  lysis, and A,/~ show PMA-induced lysis 
of 2 ×  104 control (---) or EPO-coated (--) NK lymphoma ceils by BeG-elicited peritoneal cells 
(see Table VI) in 4.5 h. The number of peritoneal cells was varied to give the peritoneal cell/tumor 
cell ratios indicated. Means ±  SE of triplicate wells are shown. 
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F~c.  3.  Lysis of 2 X 104 51Cr-labeled control (O, A, I-1) and EPO-coated (0, A, I) TLX9 cells by 
various peritoneal cells in the presence of 100 ng/ml PMA. The peritoneal cells were from untreated 
mice (Res; I, []), from mice injected intraperitoneally 5 d earlier with 1 ml of 10% thioglycollate 
medium (Thio; A, A), or from mice injected intraperitoneally 16 d earlier with 7 X 106 viable BCG 
(BCG; O, O), and their number was varied to give the peritoneal/tumor cell ratios  shown.  Points 
are means of triplicates,  for which SEM averaged 1.5 + 0.2%. 
Peritoneal  exudates  enriched  in  granulocytes  were  collected  16-20  hours  after 
intraperitoneal  injection  of sodium  caseinate,  thioglycollate  medium,  or  proteose- 
peptone.  Such  granulocyte-rich  exudates  had  little  spontaneous  cytolytic  activity 
against  EPO-coated  targets,  even at  high  E/T  ratios  (Table VI).  In contrast,  BCG- 
elicited peritoneal  ceils, which  had  been depleted  almost  completely of granulocytes CARL  F.  NATHAN  AND  SEYMOUR j.  KLEBANOFF 
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FIG.  4.  Lysis of control  (O, A, I-]) and EPO-coated TLX9 lymphoma cells (0, &, II)  by various 
peritoneal cells in the absence of PMA. Symbols and incubation conditions are as in the legend to 
Fig. 3. Points are means of triplicates, for which SEM averaged 1.3 +  0.3%. 
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on  Ficoll-Hypaque,  were  still  cytolytic  (Table  VI).  These  results  suggested  that 
activated macrophages, rather than granulocytes, mediated spontaneous cytolysis. 
BCG-elicited peritoneal ceils spontaneously lysed 50% of EPO-coated TLX9 cells 
in 4.5 h  at a peritoneal cell/tumor cell ratio of 3.6, corresponding to a  macrophage/ 
tumor cell  ratio of 1.5  (Fig.  4).  In contrast,  at  E/T  ratios as high  as  15:1  to 45:1, 
resident  peritoneal  cells  and  cells  elicited  with  thioglycollate  medium  remained 
ineffective (Table VI and Fig. 4). If TLX9 cells were not exposed to EPO, then BCG- 
activated macrophages caused <10%  spontaneous  lysis under  the conditions  tested 
(Fig. 4). 
In one experiment with P815 mastocytoma, BCG-elicited cells released 33% of the 
51Cr from the tumor cells in 4.5 h  at an E/T ratio of 4.6, when the tumor cells were 
first exposed to both EPO and BCNU as described in Table V. When either EPO or 
BCNU was omitted, lysis was not observed. 
The spontaneous lysis of EPO-coated tumor cells by BCG-activated macrophages 
reached 50% of its maximum value in -1 h, and approached a plateau at ~3 h  (Fig. 
5).  In  contrast,  there  was  almost  no  lysis of control  tumor cells  by 8  h.  Resident 
peritoneal cells failed to lyse EPO-coated tumor cells spontaneously even after 20 h 
(data not shown). 
In  a  dose-response experiment,  spontaneous  lysis of TLX9 cells by BCG-elicited 
peritoneal cells increased from 5% for control TLX9 cells to a  maximum of 89% for 
TLX9  cells  incubated  with  0.6  U  of EPO  and  then  washed.  Half-maximal  lysis 
followed exposure to 0.3 U  EPO. To determine how much of the EPO bound to the 
tumor cells, peroxidatic activity was measured immediately after adding the enzyme 
to the tumor cell suspension;  after a  10-min incubation  under standard  conditions 
(see Materials and Methods), the cells were washed four times by centrifugation, and 
peroxidatic activity was determined again. Both the initial and final assays were done 
in the presence of 0.04% Triton X100. In four such experiments (two each with TLX9 
and NK lymphomas), 22 +  5% of the enzymatic activity of the added EPO remained 
bound to the tumor ceils. 
Lysis  of EPO-coated  tumor  ceils  by  macrophages  has  been  called  spontaneous 
because no additional agent such as PMA was required. However, it was possible that 
EPO itself, or EPO-coated tumor cells, might act like PMA and stimulate a  burst of 1300  EOSINOPHIL PEROXIDASE AND MACROPHAGE-MEDIATED CYTOLYSIS 
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Fro.  5.  Time course of spontaneous  lysis of 2 X  104 51Cr-labeled control  (- - -) or EPO-coated 
(--) TLX9 lymphoma cells by 3 X 105 BCG-elicited peritoneal cells. Means +- SEM for triplicates 
are indicated. 
TABLE  VII 
EPO-coated Tumor Cells Do Not  Trigger Lysis of Adjacent Uncoated Targets 
51Cr-labeled TLX9  Unlabeled TLX9 
cells*  cells* 
Percent  Specific Lysis~: 
PMA absent§  PMA present[[ 
EPO+  None  58 --- 1¶  9l +- 3 
EPO+  EPO-  53 +  2  97 +- 6 
EPO+  EPO+  48 +__ 3  88 -  2 
EPO-  None  11 -+ 0  67 +  4 
EPO-  EPO-  8 +  1  61 +  2 
EPO-  EPO+  9 +  I  71 +  i 
* 2 X 104 cells. 
:~ After 4.5 h incubation with 3 X 105 peritoneal cells from BCG-treated mice. 
§ DMSO added, 0.033%. 
II 100 ng/ml in DMSO (final DMSO concentration, 0.033%). 
¶ Means +  SEM for triplicate cultures. 
HzO~ secretion  by  activated  macrophages  (2).  If this  were  the  case,  then  non-EPO- 
coated,  peroxide-sensitive  tumor  cells present  in  the same culture  should  be lysed as 
"innocent  bystanders"  by  the  interaction  of EPO-coated  tumor  cells  with  macro- 
phages.  As shown  in  Table  VII,  no such  lysis was  observed,  although  the bystander 
cells  were  readily  lysed  after  addition  of  PMA.  Finally,  EPO  itself  elicited  no 
detectable  HzO2 release from BCG-activated  macrophages,  as detected  by the scopo- 
letin assay  (data  not shown). 
Dependence of Cytolysis on H2Oz. In six experiments, catalase inhibited the spontaneous 
lysis of EPO-coated  TLX9  or NK  lymphoma  cells by BCG-elicited peritoneal cells by 
an average of 98%  (Table VIII). Catalase which had been inactivated by heating had 
little or no  inhibitory  effect  (Table  VIII).  23  U  of catalase/ml  inhibited  cytolysis by 
50%  (Fig.  6B).  Results  were  similar  with  PMA-induced  cytolysis  of  EPO-coated 
targets  (e.g., Fig.  7). Thus, both PMA-induced  and spontaneous  cytolysis appeared  to 
depend on H202. 
Dependence  of Cytolysis  on  the  Enzymatic  Action  of EPO.  Cationic  proteins  from  the CARL  F.  NATHAN AND  SEYMOUR J.  KLEBANOFF  1301 
TABLE VIII 
Inhibition of Cytolysis by Catalase 
Percent inhi- 
Lysis with-  Percent inhi-  bition with 
Experi-  Target*  Catalase  out cata-  bition with 
ment  lase:~  catalase§  boiled cata- 
lose§ 
U/ml 
1  TLX9  3,000  56.3  102  ND l[ 
2  TLX9  3,000  59.5  97.5  ND 
3  TLX9  1,000  48.0  103  ND 
4  NK  300  68.9  97.4  11.4 
5  NK  300  29.9  91.0  0.0 
6  TLX9  30  24.7  99.6  3.2 
* 2 X  104 EPO-coated tumor cells. 
:l: Percent specific lysis after 4.5 h incubation with 3 ×  l0  s peritoneal cells 
injected with BCG or sodium caseinate. 
§ Calculated as described in Materials and Methods. 
U Not done. 
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Fro.  6.  Effect of sodium azide (A) and catalase  (B) on spontaneous lysis of 2 x  104 51Cr-labeled, 
EPO-coated NK lymphoma cells by 3 ×  105 BCG-elicited peritoneal ceils in 4.5 h. In B, (O) indicate 
results with heat-inactivated catalase. Means + SEM for triplicates are shown. 
granules of eosinophils  (31)  or neutrophils  (32)  may be tumoricidal independent of 
peroxidase activity. EPO, although a cationic protein, did not seem to exert its toxicity 
through this property under our conditions, because EPO was nontoxic in the absence 
of H202 (Table IV). That  EPO was functioning enzymatically in promoting cytolysis 
was further suggested by two additional approaches. 
First,  the  peroxidase  inhibitor sodium  azide  inhibited spontaneous lysis of EPO- 
coated TLX9  or NK  lymphoma  cells by BCG-activated macrophages  by a  mean of 
102% in four experiments (Table IX). Azid~ at 2.6 X  10  -5 M  afforded 50% inhibition 
(Fig. 6 A). Sodium azide would not be expected  to affect  nonenzymatic functions of 
EPO  related  to  its  cationic  nature.  Second,  we  exposed  NK  lymphoma  cells  to 
protamine sulfate, a  cationic protein  (33)  lacking in peroxidase activity. Preliminary 1302  EOS|NOPHIL  PEROXIDASE  AND  MACROPHAGE-MEDIATED  CYTOLYSIS 
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Fro.  7.  Comparison of untreated, protamine-treated, or EPO-treated NK lymphoma cells for their 
susceptibility to  PMA-induced lysis (upper panel)  or spontaneous lysis (lower  panel)  by 3  ×  105 
BCG-elicited peritoneal cells in 4.5 h. 51Cr release was measured from 2 X  104 NK lymphoma cells 
incubated in  the presence of 300  U/ml of native catalase  (I-1) or heat-inactivated catalase  (NI). 
Means +  SEM for triplicates are indicated. Values for percent spontaneous release with native and 
boiled catalase were: 8.5, 9.2 (untreated NK cells); 9.8, 9.3 (protamine-treated NK ceils, 0.06 mg/ 
ml for  l0 min); 9.4,  t0.8 (EPO-treated NK cells). 
TABLE  IX 
Inhibition of Cytolysis by Azide 
Experi-  Target*  NaN3  Lysis without  Percent inhibi- 
ment  azide:~  tion with azide§ 
mM 
1  TLX9  1.0  56.3  105 
2  TLX9  1.0  59.5  106 
3  NK  0.3  68.9  95.8 
4  TLX9  0.03  48.0  99.8 
For explanation of notes, see Table VIII. 
experiments demonstrated that protamine sulfate alone was toxic to NK lymphoma 
cells  (data not shown). The  highest concentration of protamine sulfate that did not 
itself elevate  the spontaneous release  of 51Cr from  the tumor cells  was 0.06  mg/ml. 
NK lymphoma cells exposed to this concentration of protamine sulfate were unharmed 
by  BCG-activated  macrophages,  with  or  without  PMA,  whereas  the  tumor  cells 
exposed to EPO  (<0.02  mg/ml)  were extensively lysed by the macrophages  (Fig.  7). 
As before, lysis was abolished by catalase  (Fig.  7). 
Discussion 
Many  reports  have  documented  that  myeloperoxidase,  lactoperoxidase,  or  EPO 
can  enhance  the  lysis  of  tumor  cells  by  H202  and  halide,  whether  the  H202  is CARL F.  NATHAN AND SEYMOUR J.  KLEBANOFF  1303 
preformed, generated by enzymes in situ,  or released by leukocytes stimulated with 
particles, lectins, or phorbol esters  (25,  29,  34-40). The work reported here extends 
such observations in two ways. 
First, EPO catalyzed the lysis of tumor cells by H202 released spontaneously from 
activated macrophages in the absence of exogenous triggering agents. This constitutes 
a  new,  unusually  rapid,  and  potent  form  of spontaneous  macrophage-mediated 
cytolysis.  Second,  this  peroxidase-dependent  cytotoxicity occurred  in  a  complex, 
serum-containing  tissue  culture  medium  without  further addition  of halides.  The 
medium was physiologic, in that it could support the replication of TLX9, P815, and 
P388  tumor  cells  at  approximately the  same  rate  as  in  the  peritoneal  cavity  (C. 
Nathan, unpublished observations). When peroxidases are in solution, their cytotoxic 
effects are readily inhibited by serum proteins, which compete with cells for the toxic 
products of the peroxidase system. In contrast, EPO, which is highly cationic (pI > 
11)  (21), bound to the surface of tumor cells, where it efficiently promoted peroxide- 
dependent cytotoxicity, despite the presence in the medium of competing compounds 
such as serum proteins. 
Cell-bound EPO sensitized each of four different types of tumor cells to H20~. For 
three of these, we quantified the degree of sensitization to enzymatically generated 
H202.  TLX9 lymphoma cells, which  are relatively sensitive to H202  (30),  became 
-15  times  more sensitive after exposure to  EPO.  NK  lymphoma cells,  which  are 
comparatively resistant  to H202  (30), became up  to  76-fold more susceptible after 
treatment with EPO. As a consequence, there were fluxes of H202 that lysed none of 
the control tumor cells, but essentially all of the EPO-coated cells. On the other hand, 
the peroxide sensitivity of P815 mastocytoma cells, which is normally intermediate 
between TLX9 and NK cells, did not appear to be affected by EPO alone. However, 
when EPO-treated P815 cells were also exposed for  10 min to BCNU  to inactivate 
glutathione reductase, an enzyme involved in H20~ catabolism (30), they became 13 
times more sensitive to H202 than cells treated with neither EPO nor BCNU  (2.8 
times more sensitive than cells treated with BCNU alone). The basis for this variation 
in response to EPO among different tumors is unknown, but could relate to differences 
in binding of the enzyme. 
The spontaneous lysis  of EPO-coated tumor cells by activated macrophages was 
rapid (50% at 2 h at a macrophage/tumor cell ratio of 6:1). In contrast, control target 
cells were almost completely spared during an 8-h incubation with activated macro- 
phages.  In  assays  lasting  4.5  h,  macrophage/tumor  cell  ratios  of  1.5:1  to  4.6:1 
produced 50% spontaneous  lysis  of EPO-coated targets.  Macrophages  activated by 
injection of mice with either BCG or sodium caseinate were able to lyse EPO-coated 
tumor cells spontaneously. However, resident peritoneal macrophages or macrophages 
elicited  with  thioglycollate  medium  were  ineffective, and  peritoneal  granulocytes 
showed marginal cytolytic activity only at high E/T ratios. Spontaneous lysis of EPO- 
coated tumor cells by activated macrophages was inhibited completely by catalase, 
with  50%  inhibition  by  23  U/ml,  but  not  by boiled  catalase.  Thus,  spontaneous 
cytolysis appeared to require H202. 
We attributed spontaneous cytolysis in this setting to macrophages, for the following 
reasons. A low level of spontaneous secretion of H202 by activated macrophages has 
been measured biochemically (2), and is consistent with the known elevation ofhexose 
monophosphate shunt activity in activated macrophages at rest (41-45). In contrast, 1304  EOSINOPHIL  PEROXIDASE AND MACROPHAGE-MEDIATED CYTOLYSIS 
secretion of H202 by BCG-elicited peritoneal lymphocytes could not be detected (2). 
Very tow  levels of spontaneous  cytolysis of EPO-coated  tumor cells  resulted  from 
incubation  with  large  numbers  of peritoneal  granulocytes.  However, granulocyte- 
depleted populations, consisting almost exclusively of macrophages and lymphocytes, 
remained spontaneously cytolytic. 
We have referred to cytolysis as spontaneous when there was no requirement for 
exogenous agents known  to trigger macrophages.  EPO  itself did  not  appear to be 
such an agent. EPO did not elicit detectable H202 release from activated macrophages, 
nor did EPO-coated tumor cells induce macrophages to lyse tumor cells not coated 
with EPO. However, as with any system of apparently spontaneous cytotoxicity, it is 
possible that stimuli endogenous to the assay may have elicited a cytotoxic response. 
Such  stimuli  could include components of the  medium,  the surface of the culture 
vessel, or the tumor cells themselves (46). 
EPO is  a  cationic protein, and  like other granulocyte cationic proteins  (31,  32), 
might be tumoricidal by virtue of this property. However, no cytotoxicity was seen 
with EPO unless H202 was added. The cytotoxicity of EPO plus H2Oz was abolished 
completely by  low  concentrations  of the  peroxidase  inhibitor  sodium  azide  (50% 
inhibition at 2.6 ×  10  -5 M). This agrees closely with the concentration of azide found 
previously  to  inhibit  the  enzymatic  activity  of EPO  (47).  Azide  did  not  inhibit 
cytotoxicity by  reducing  macrophage  H202  production  (data  not  shown).  When 
tumor cells were not exposed to EPO, then PMA-triggered cytolysis by macrophages 
was either unaffected by azide or augmented by it (4).  Finally, protamine sulfate, a 
cationic protein (pI ~  12)  (33), which was cytotoxic in the absence of added H202 at 
relatively high concentrations, did not support the expression of spontaneous cytotox- 
icity by activated macrophages at  protein concentrations at  least  threefold greater 
than those at which EPO was effective. 
It is not known to what extent eosinophils release their granule contents in a tumor 
bed, or with what efficiency EPO might bind to tumor cells in vivo. However, under 
our experimental conditions, the EPO contained in ~8 ×  104 eosinophils appeared to 
be sufficient to sensitize 1 ×  106 TLX9 lymphoma cells to undergo 89% specific lysis 
in  the  presence  of 8  ×  10  a  BCG-activated  macrophages.  By  this  estimate,  the 
peroxidase in 1 eosinophil could augment maximally the spontaneous in vitro cytolytic 
capacity of 100 macrophages. 
Titrations of the cytolytic activity of peritoneal cells and of glucose oxidase plus 
glucose suggest that BCG-activated macrophages would produce the observed degree 
of lysis of EPO-coated tumor cells if the macrophages spontaneously released about 
0.26 nmol of H202 per rain. This figure is an order of magnitude higher than the rate 
of spontaneous H202 release previously observed with BCG-activated macrophages in 
suspension  (0.02  nmol/min)  (2).  There  are  several  possible  explanations  for  this 
apparent discrepancy. 
First,  the  proximity of macrophages  to  tumor  cells  may  have  raised  the  local 
concentration of H202 to a  level higher than would be achieved by soluble glucose 
oxidase with the same rate of H202 generation. Second, the peritoneal cell preparations 
may have supplied  factors augmenting the efficiency of EPO.  Thus, production of 
acid by macrophages in the vicinity of tumor cells may have lowered the pericellular 
pH. At the same concentrations of H202 and EPO, there is far more toxicity to tumor 
cells at pH 6 than at pH 7 (25). Peritoneal cell preparations may have supplied traces CARL F.  NATHAN AND SEYMOUR J.  KLEBANOFF  1305 
of a halide or other oxidizable cofactor. Iodide exerts a synergistic effect with chloride 
in permitting the halide-dependent toxicity of the EPO-H202 system (25). In addition, 
the BCG-elicited peritoneal cell populations contained 0.75 -¢- 0.25% mast cells (mean 
+  SEM, n  =  12). H202 triggers mast  cell degranulation  (38,  48, 49)  and  mast  cell 
granules markedly enhance the cytotoxicity of EPO for tumor cells (38). 
Finally, macrophages secrete additional cytotoxic substances besides H202 (8-11). 
One of these, termed cytolytic factor (11), can exert a synergistic effect together with 
H202, so that tumor cells are lysed at concentrations of each substance which are not 
cytolytic separately (50).  Thus, whereas H202 was necessary for spontaneous macro- 
phage-mediated cytolysis of EPO-coated targets, other factors may have increased the 
efficiency of lysis. 
The findings presented here and earlier (50) raise the possibility that spontaneously 
secreted H202 may contribute, along with other factors, to the cytotoxicity occurring 
during more prolonged contact of activated macrophages with tumor cells (51) in the 
absence of EPO. In summary, an enzyme from eosinophils and an inorganic substrate 
released spontaneously by activated macrophages together lysed tumor cells that were 
unharmed  by either agent alone. Cytotoxicity was  rapid  and  potent, and  occurred 
readily in a medium with a composition similar to that of extracellular fluid. These 
features encourage the speculation that macrophages and eosinophils may cooperate 
in  exerting extracellular cytotoxicity when  they migrate together into tumor beds, 
sites of parasitic infestation, or other foci of inflammation. 
Summary 
Eosinophil peroxidase (EPO), a cationic protein purified from horse blood, adhered 
to four different types of tumor cells, markedly potentiating their lysis by preformed 
or enzymatically generated H202 (up to 76-fold, as assayed in serum-containing tissue 
culture medium without supplemental  halide).  Similarly, compared with uncoated 
tumor cells, EPO-coated tumor cells were up to 32 times more sensitive to lysis when 
incubated with macrophages or granulocytes whose respiratory burst  was triggered 
by  PMA.  However,  EPO-coated  tumor  cells  were  also  readily  lysed  by  bacillus 
Calmette-Gu6rin-activated  macrophages  in  the  absence  of  exogenous  triggering 
agents. This spontaneous cytolysis was rapid  (50%  at  2 h)  and potent  (50%  lysis at 
macrophage/tumor cell ratios of 1.5 to 4.6), and was observed with both a peroxide~ 
sensitive tumor (TLX9) and a peroxide-resistant tumor (NK lymphoma). Under the 
conditions  used,  neither  EPO  alone  nor  macrophages  alone  were  spontaneously 
cytolytic. Neither EPO nor EPO-coated tumor cells triggered a detectable increment 
in H202 release from macrophages. Nonetheless, spontaneous macrophage-mediated 
cytolysis of EPO-coated  tumor  cells  was  completely inhibitable  by  catalase  (50% 
inhibition, 23 U/ml), although not by heated catalase, indicating a requirement for 
H202. Cytolysis was also completely inhibitable by azide (50% inhibition, 2.6 X  10  -5 
M),  indicating  a  requirement  for enzymatic  activity  of EPO.  Thus,  a  cytophilic 
peroxidase from eosinophils and H202 spontaneously released from activated macro- 
phages interacted synergistically in a physiologic medium to destroy tumor cells. 
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Dr. Z. A. Cohn for helpful discussions and critical review of the manuscript. 
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